Pasithea Therapeutics Corp. (KTTAW) Non Operating Income (2021 - 2026)

Pasithea Therapeutics has disclosed Non Operating Income across 6 years of filings, most recently posting $439430.0 for Q2 2026.

• In Q2 2026, Non Operating Income rose 363.82% year-over-year to $439430.0; the TTM figure through Jun 2026 stood at $2.7 million (up 793.11% YoY), while the FY2025 annual figure was $429612.0, up 24.39% from the prior year.
• Non Operating Income came in at $439430.0 for Q2 2026 at Pasithea Therapeutics, down from $2.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.0 million in Q1 2026 to a low of -$335317.0 in Q3 2022.
• Average Non Operating Income over 5 years is $271169.1, with a median of $117518.0 recorded in 2023.
• Year-over-year, Non Operating Income tumbled 106.41% in 2023 and jumped 1616.39% in 2026.
• Over 5 years, Non Operating Income stood at -$335317.0 in 2022, then surged by 135.05% to $117518.0 in 2023, then sank by 30.32% to $81889.0 in 2024, then soared by 77.43% to $145294.0 in 2025, then surged by 202.44% to $439430.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $439430.0 in Q2 2026, $2.0 million in Q1 2026, and $145294.0 in Q4 2025.